Literature DB >> 22859254

Creatinine-based vancomycin dosing regimens in neonates: there is more to consider than the variation in drug assay.

Karel Allegaert1, John N van den Anker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22859254     DOI： 10.1002/j.1875-9114.2012.01180.x

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN： 0277-0008            Impact factor:   4.705


× No keyword cloud information.
  3 in total

1.  Vancomycin monitoring in children using bayesian estimation.

Authors:  Jennifer Le; Becky Ngu; John S Bradley; William Murray; Austin Nguyen; Lyn Nguyen; Gale L Romanowski; Tiana Vo; Edmund V Capparelli
Journal:  Ther Drug Monit       Date:  2014-08       Impact factor: 3.681

2.  Evaluation of Vancomycin Use in Late-Onset Neonatal Sepsis Using the Area Under the Concentration-Time Curve to the Minimum Inhibitory Concentration ≥400 Target.

Authors:  Jiraganya Bhongsatiern; Chris Stockmann; Jessica K Roberts; Tian Yu; Kent E Korgenski; Michael G Spigarelli; Pankaj B Desai; Catherine M T Sherwin
Journal:  Ther Drug Monit       Date:  2015-12       Impact factor: 3.681

3.  Different Vancomycin Immunoassays Contribute to the Variability in Vancomycin Trough Measurements in Neonates.

Authors:  Janko Samardzic; Anne Smits; Isabel Spriet; Ivan Soldatovic; Andrew Atkinson; Milica Bajcetic; John N Van Den Anker; Karel Allegaert
Journal:  Biomed Res Int       Date:  2016-08-21       Impact factor: 3.411
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.